The strength of this study was that, for the first time, we analyzed IL-10 rs1800871, rs1800872, and rs1800896 and IL-10 serum levels in patients with multiple sclerosis in the Baltic population and compared them with healthy controls without other diseases. This evidence concerns the gene IL10 and multiple sclerosis.